REGENXBIO Inc.
DE ˙ DB ˙ US75901B1070
6,20 € ↓ -0,10 (-1,59%)
2026-06-02
AKTIENPREIS
SecurityDE:RB0 / REGENXBIO Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership285,174 shares
Latest Disclosed Value $ 2,389,758
Millennium Management Llc ownership in RB0 / REGENXBIO Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 285,174 shares of REGENXBIO Inc. (DE:RB0) valued at $1,967,701 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 214,666 shares of REGENXBIO Inc.. This represents a change in shares of 32.85% during the quarter. The current value of the position is $1,768,079 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (RB0) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:RB0 / REGENXBIO Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REGENXBIO COM 75901B107 285,174 70,508 32.85 2,390 -22.71 0.0010
2026-02-17 2025-12-31 13F REGENXBIO COM 75901B107 214,666 128,007 147.71 3,091 269.74 0.0013
2025-11-14 2025-09-30 13F REGENXBIO COM 75901B107 86,659 -25,290 -22.59 836 -9.03 0.0004
2025-08-14 2025-06-30 13F REGENXBIO COM 75901B107 111,949 -220,880 -66.36 919 -61.37 0.0004
2025-05-15 2025-03-31 13F REGENXBIO COM 75901B107 332,829 -989,515 -74.83 2,380 -76.72 0.0013
2025-02-14 2024-12-31 13F REGENXBIO COM 75901B107 1,322,344 1,061,187 406.34 10,222 273.17 0.0050
2024-11-14 2024-09-30 13F REGENXBIO COM 75901B107 261,157 -45,330 -14.79 2,740 -23.60 0.0013
2024-08-14 2024-06-30 13F REGENXBIO COM 75901B107 306,487 140,666 84.83 3,586 2.63 0.0017
2024-05-15 2024-03-31 13F REGENXBIO COM 75901B107 165,821 110,498 199.73 3,494 251.76 0.0015
2024-02-14 2023-12-31 13F REGENXBIO COM 75901B107 55,323 -146,399 -72.57 993 -70.09 0.0004
2023-11-14 2023-09-30 13F REGENXBIO COM 75901B107 201,722 -2,621 -1.28 3,320 -18.71 0.0017
2023-08-14 2023-06-30 13F REGENXBIO COM 75901B107 204,343 -514,868 -71.59 4,085 -69.97 0.0020
2023-05-15 2023-03-31 13F REGENXBIO COM 75901B107 719,211 697,379 3,194.30 13,600 2,647.47 0.0078
2023-02-14 2022-12-31 13F REGENXBIO COM 75901B107 21,832 4,789 28.10 495 10.00 0.0003
2022-11-14 2022-09-30 13F REGENXBIO COM 75901B107 17,043 17,043 450 0.0003
2022-08-15 2022-06-30 13F REGENXBIO COM 75901B107 0 -218,316 -100.00 0 -100.00
2022-05-16 2022-03-31 13F REGENXBIO COM 75901B107 218,316 189,703 663.00 7,246 674.15 0.0038
2022-02-14 2021-12-31 13F REGENXBIO COM 75901B107 28,613 22,441 363.59 936 261.39 0.0005
2021-11-15 2021-09-30 13F REGENXBIO COM 75901B107 6,172 -188,955 -96.84 259 -96.58 0.0002
2021-08-16 2021-06-30 13F REGENXBIO COM 75901B107 195,127 -17,294 -8.14 7,581 4.62 0.0047
2021-05-17 2021-03-31 13F REGENXBIO COM 75901B107 212,421 197,735 1,346.42 7,246 987.99 0.0052
2021-02-16 2020-12-31 13F REGENXBIO COM 75901B107 14,686 716 5.13 666 73.44 0.0005
2020-11-16 2020-09-30 13F REGENXBIO COM 75901B107 13,970 -140,374 -90.95 384 -93.24 0.0005
2020-08-14 2020-06-30 13F REGENXBIO COM 75901B107 154,344 154,344 5,684 0.0078
2020-05-14 2020-03-31 13F REGENXBIO COM 75901B107 0 -105,496 -100.00 0 -100.00
2020-02-14 2019-12-31 13F REGENXBIO COM 75901B107 105,496 -23,164 -18.00 4,322 9.56 0.0054
2019-08-14 2019-06-30 13F G1 THERAPEUTICS COM 75901B107 128,660 128,660 3,945 0.0059
2019-02-15 2018-12-31 13F/A-1 REGENXBIO COM 75901B107 0 -130,238 -100.00 0 -100.00
2018-11-14 2018-09-30 13F REGENXBIO COM 75901B107 130,238 116,336 836.83 9,833 886.26 0.0121
2018-08-14 2018-06-30 13F REGENXBIO COM 75901B107 13,902 -216,935 -93.98 997 -85.53 0.0013
2018-05-15 2018-03-31 13F REGENXBIO COM 75901B107 230,837 134,479 139.56 6,890 115.04 0.0092
2018-02-14 2017-12-31 13F REGENXBIO COM 75901B107 96,358 96,358 3,204 0.0044
2017-11-14 2017-09-30 13F REGENXBIO COM 75901B107 0 -320,247 -100.00 0 -100.00
2017-08-14 2017-06-30 13F REGENXBIO COM 75901B107 320,247 -421,990 -56.85 6,325 -55.85 0.0113
2017-05-15 2017-03-31 13F REGENXBIO COM 75901B107 742,237 282,123 61.32 14,325 67.84 0.0262
2017-02-14 2016-12-31 13F REGENXBIO COM 75901B107 460,114 -13,738 -2.90 8,535 28.56 0.0179
2016-11-14 2016-09-30 13F REGENXBIO COM 75901B107 473,852 411,059 654.63 6,639 1,222.51 0.0111
2016-08-15 2016-06-30 13F REGENXBIO COM 75901B107 62,793 46,961 296.62 502 193.57 0.0011
2016-05-16 2016-03-31 13F REGENXBIO COM 75901B107 15,832 -61,243 -79.46 171 -86.63 0.0004
2016-02-16 2015-12-31 13F REGENXBIO COM 75901B107 77,075 20,772 36.89 1,279 3.15 0.0027
2015-11-16 2015-09-30 13F REGENXBIO COM 75901B107 56,303 56,303 1,240 0.0024
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F REGENXBIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F REGENXBIO COM Call 21,300 206 n/a n/a n/a
2019-11-14 2019-09-30 13F REGENXBIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-15 2019-06-30 13F/A REGENXBIO COM Call 35,000 -30.00 1,798 -37.26 n/a n/a n/a
2019-05-14 2019-03-31 13F REGENXBIO COM Call 50,000 2,866 n/a n/a n/a
2018-11-14 2018-09-30 13F REGENXBIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F REGENXBIO COM Call 22,200 1,593 n/a n/a n/a
2018-05-15 2018-03-31 13F REGENXBIO COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F REGENXBIO COM Call 200,000 587.29 6,650 593.43 n/a n/a n/a
2017-11-14 2017-09-30 13F REGENXBIO COM Call 29,100 959 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-17 2021-03-31 13F REGENXBIO COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F REGENXBIO COM Put 15,000 680 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.